SCHEMBL17523318

SCHEMBL17523318

CC[C@@H]1NC(=O)C[C@H]1c1ccc(OC)c(OC2CCCC2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 18/20 0.60
PDE4A P27815 10/20 0.60
PDE4C Q08493 8/20 0.60
PDE4D Q08499 8/20 0.60
CYP3A4 P08684 2/20 0.58
VEGFA P15692 1/20 0.58
ALDH1A1 P00352 1/20 0.58
LMNA P02545 1/20 0.58
CYP1A2 P05177 1/20 0.58
MAPT P10636 1/20 0.58
CYP2C9 P11712 1/20 0.58
ALOX15 P16050 1/20 0.58
CREBBP Q92793 1/20 0.58
KDM4E B2RXH2 1/20 0.58
PDE5A O76074 1/20 0.58
TNF P01375 1/20 0.58
MAPK1 P28482 1/20 0.58
BLM P54132 1/20 0.58
PDE1A P54750 1/20 0.58
PDE1B Q01064 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16056010 0.90 PDE4B (0.58) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL7406620 0.85 PDE4B (0.63) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL16056262 0.81 PDE4B (0.59) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL28293800 0.81 PDE4B (0.58) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL3173894 0.76 PDE4B (0.77) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL21531660 0.75 PDE4B (0.47) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL7295147 0.74 PDE4B (0.57) PDE4BPDE4APDE4CPDE4DCYP3A4
Rolipram SCHEMBL3719855 0.74 PDE4A (1.00) PDE4BPDE4APDE4CPDE4DCYP3A4
SCHEMBL7294928 0.74 PDE4B (0.68) PDE4BPDE4APDE4CPDE4DCYP3A4
(-)-Rolipram SCHEMBL576805 0.74 PDE4A (1.00) PDE4BPDE4APDE4CPDE4DCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160039827-A1 ACTIVATION OF CARBONYL BETA-CARBONS FOR CHEMICAL TRANSFORMATIONS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160039827-A1 ACTIVATION OF CARBONYL BETA-CARBONS FOR CHEMICAL TRANSFORMATIONS CBR1, CBR3, CAT PDE4B 1513/4885PDE4A 1813/4885PDE4C 1657/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.